<DOC>
	<DOCNO>NCT01841580</DOCNO>
	<brief_summary>Approximately 70 million people world-wide affected glaucoma , 6.7 million bilateral blindness.5 Elevated intro-ocular pressure major modifiable risk factor glaucoma , reduce intraocular pressure consistently low level delay disease progression therefore , blindness.6 Topical intraocular pressure -lowering medication remain first-line treatment glaucoma , surgical intervention play secondary role case suboptimally control medication alone . In study , plan assess change tear protein trabeculectomy patient operation . It hop study could help u gain understanding possible mechanism accounting development dry eye disease glaucoma patient , could help u develop well screen modality therapeutic agent glaucoma patient risk prevent development dry eye disease .</brief_summary>
	<brief_title>Proteomic Profiles Trabeculectomy Patients</brief_title>
	<detailed_description>Study Objectives Purpose There two primary aim study : 1 . To assess change tear proteomic profile pre-trabeculectomy post-trabeculectomy patient 2 . To assess change clinical sign eye tear film well dry eye symptom . Study Material Human Tears collect patient SNEC clinic Study Design : 120 patient recruit study ( detail describe ) . Schirmers I test , Tear Osmolarity , Tear Break Up Time ( TBUT ) , Anterior segment optical coherence tomography ( ASOCT ) Impression cytology do study visit . Subjective symptom severity dry eye disease assess Visual Analog Scale ( VAS ) . No . visit : There 4 visit study . Visit 1 : Pre-trabeculectomy operation Visit 2 : 6 month trabeculectomy surgery Visit 3 : 1 year trabeculectomy surgery Visit 4 : 3 year trabeculectomy surgery Selection Withdrawal Subjects Recruitment Criteria 1 . 120 patient recruit glaucoma clinic SNEC 2 . Patients age ≥ 21 year old 3 . Patients require trabeculectomy operation Treatment subject Study Procedures : 1 . Fluorescein stain use visualize patient eye . 2 . Schirmer 's test use measure amount tear production 1 . A small strip filter paper insert inside low eyelid 2 . A topical aneasthetic place eye filter paper prevent tear due irritation paper 3 . The eye close 5 minute . 4 . The paper remove amount moisture measure 3 . Impression cytology perform collect superficial conjunctival cell analysis 1 . While eye still anaesthetize Schirmer 's test , one end filter paper impress upon temporal conjunctiva whilst hand grasp place blunt smooth edged forceps . 2 . The filter paper remove conjunctiva peel motion 2-3 second . 3 . The paper place eppendorf tube future analysis . 4 . Tear osmolarity , Tear Break Up Time ( TBUT ) measure patient ) Tear osmolarity measure use osmolarity chip , 3 chip per eye 5 . Anterior segment optical coherence tomography perform assess tear meniscus image conjunctivochalasis ) The patient ask look target instrument blink normally . The instrument scan low eyelid margin image tear meniscus conjunctivochalasis 6 . Symptoms severity dry eye disease assess Visual Analog Scale ( VAS ) system Assessment efficacy Outcome Measures 1 . Symptoms severity dry eye disease quantify base Visual Analog Scale ( VAS ) 11 2 . Amount moisture filter paper measure Schirmer 's test 3 . Clinical assessment dry eye disease Tear break time ( TBUT ) Tear Osmolarity measurements 4 . Tear meniscus height area image obtain optical coherence tomography Target sample size 120 subject enrol study .</detailed_description>
	<criteria>1 . 120 patient recruit glaucoma clinic SNEC 2 . Patients age ≥ 21 year old 3 . Patients require trabeculectomy operation</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Tear protein profile</keyword>
	<keyword>Longitudinal</keyword>
	<keyword>Ocular surface damage</keyword>
	<keyword>Trabeculectomy</keyword>
</DOC>